Government debt to SAMED members has reached critical levels, threatening care continuity and straining companies. Meanwhile, rapid regulatory and policy changes are impacting market access, reimbursement, and compliance. To help CEOs navigate this volatile environment, SAMED invites senior executives to its first 2026 CEO Pulse session, offering strategic insights and practical guidance.

Register: Click Here

Programme:

1. Government Debt Update 
   Monica Lucas, SAMED Board Member and Chairperson: Market Sustainability Committee

• Update on recent engagements and progress.

2. Prescription of Debt: What CEOs Must Do Now
   Karabo Motsamai, Senior Legal Advisor, Dentons

• Practical legal guidance on prescription risk, mitigation strategies, and actions executives should be taking to protect their organisations.

3. Healthcare and Medtech Landscape and Legislative Update
   Elsabé Klinck, Managing Director, Klinck & Samuels

A comprehensive policy and legislative update covering:

• SAHPRA key developments
• Progress and implications of National Health Insurance (NHI)
• Regulatory and funding dynamics within Medical Schemes
• Updates from the Council for Medical Schemes (CMS)
• Other relevant regulatory and policy developments impacting the medtech sector

Receive critical insight into the regulatory environment enabling informed strategic and operational decision-making.